Correction to: Safety considerations when prescribing immunosuppression medication to pregnant women by C. Gerosa et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=ieds20
Expert Opinion on Drug Safety
ISSN: 1474-0338 (Print) 1744-764X (Online) Journal homepage: https://www.tandfonline.com/loi/ieds20
Erratum
To cite this article: (2015) Erratum, Expert Opinion on Drug Safety, 14:6, 1009-1009, DOI:
10.1517/14740338.2015.1042673
To link to this article:  https://doi.org/10.1517/14740338.2015.1042673
Published online: 28 Apr 2015.
Submit your article to this journal 
Article views: 212
View related articles 
View Crossmark data
Erratum
Correction to: Safety considerations when prescribing immunosuppression medication to pregnant women
Gerosa M, Meroni PL, Cimaz R. Safety considerations when prescribing immunosuppression medication to pregnant women.
Expert Opin Drug Saf 2014 Dec;13(12):1591-9.
Following publication of this article, PL Meroni noted that his second affiliation had not been listed on the paper. The inclusion
of this affiliation is important and required by his second institution.
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